EKSO | tickerfilter.com

Fundamental analysis

36%

Profitability 50%

Dept financing 25%

Liquidity 37%

Performance 25%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

0.83%

1 Month

-9.25%

3 Months

-48.31%

6 Months

-40.20%

1 Year

-64.33%

2 Year

-50.81%

Key data

Stock price

$0.62

P/E Ratio

0.00

DAY RANGE

$0.62 - $0.62

EPS

$0.00

52 WEEK RANGE

$0.62 - $3.13

52 WEEK CHANGE

-$67.55

MARKET CAP

22.133 M

YIELD

N/A

SHARES OUTSTANDING

18.444 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

10/24/2024

BETA

0.46

PUBLIC FLOAT

AVERAGE 10 VOLUME

$142,333

AVERAGE 30 VOLUME

$134,534

Company detail

CEO: Steven Sherman
Region: US
Website: eksobionics.com
Employees: 60
IPO year: -

Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

Ekso Bionics Holdings, Inc. designs, develops, sells, rents, and rents exoskeleton products. EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury. The company has a license agreement with Lockheed Martin Corporation.

EKSO - EKSO BIONICS HOLDINGS, INC.